Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-000182

Director sold 40,000 shares at an average $22.59 ($903,650)

  • Director acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Hagan Joseph P Director 2022-01-03 Option exercise +40,000 $5.08 $203,200 43,500 D
Hagan Joseph P Director 2022-01-03 Sale −39,366 $22.58 $888,884 4,134 D
Hagan Joseph P Director 2022-01-03 Sale −634 $23.29 $14,766 3,500 D
Derivatives
Hagan Joseph P Director 2022-01-03 Option exercise · Stock Option (right to buy) −40,000 10,000 D
Open-market sales · 40,000 sh · avg $22.59 · $903,650
Loading xslF345X03/wf-form4_164133098196321.xml…